openPR Logo
Press release

Critical Care Therapeutics Market Size, Share, Trends, Analysis and Forecasts To 2021

02-03-2017 01:24 PM CET | Health & Medicine

Press release from: MRC

Market Research analysts forecast the global critical care therapeutics market to grow at a CAGR of 3.62% during the period 2017-2021.

The following companies as the key players in the global critical care therapeutics market: CSL Behring, Grifols, Kedrion Biopharma, Octapharma, and Shire.

Other Prominent Vendors in the market are: Abeona Therapeutics, ADMA Biologics, Albumedix, Armetheon, Asklepios BioPharmaceutical, Aspen Pharma, Baxter, Bayer HealthCare, Bio Products Laboratory, BioDelivery Sciences, Biogen Idec, BioMarin, Biotest Pharmaceuticals, Bristol-Myers Squibb, Catalyst Biosciences, China Biologic Products, Cosmo Pharmaceuticals, Kamada, King Pharmaceuticals, Medxbio, Merck, Mitsubishi Tanabe Pharma, Novo Nordisk, Novozymes, Portola Pharmaceuticals, ProMetic Life Sciences, rEVO Biologics, Rockwell Medical, Sanquin, Shanghai RAAS, Teva Pharmaceutical, The Medicines Company, Thermo Fisher Scientific, Tianjin SinoBiotech & Beijing Bio-Fortune, and Ventria Bioscience.

Download Sample Report @

Commenting on the report, an analyst from Technavio’s team said: “One trend in market is establishment of plasma fractionation facilities in emerging economies by global players. Plasma fractionation in developed countries is proving very costly, so there has been a growing focus of vendors to tap the emerging economies such as the Middle East, Africa, China, and India. These geographies become a favorite due to the easy availability of skilled personnel, raw materials, cheap labor and land, a larger volume of available plasma due to large population base, and supportive government regulations. However, currently the presence of plasma fractionation facilities is very much limited to China within emerging countries, but in future, the incentives listed above should be driving the vendors to establish more facilities in these regions. For instance, in 2010, Celestial Biologicals, an associate company of Intas Biopharmaceuticals, in collaboration with GE Healthcare started a plasma fractionation facility in India. Going forward, to benefit from the unmet demand in the emerging markets and the incentives of opening such facilities in the region, would drive global players to open number of such facilities in the region.

According to the report, one driver in market is increasing surgical procedures. The increasing surgical procedures such as hip and knee replacements will increase the risk of DVT, thereby driving the market growth. Surgeries often result in long periods of immobility, thus increasing the chances of developing DVT due to reduced blood flow. It is reported that over a million Americans undergo joint replacement surgeries every year. Individuals undergoing knee replacement and hip replacement surgeries have an increased likelihood of developing DVT. For instance, according to the CDC 2015 report, around 719,000 knee replacement surgeries and 332,000 hip replacement surgeries are performed in the US every year.

Further, the report states that one challenge in market is high regulations of plasma products. Manufacturers of critical care therapeutics need to follow rigorous and distinct sets of regulatory guidelines like the adherence to current good manufacturing practices (cGMP) during the donation and processing of the plasma products. These guidelines are applied both for the collection of plasma from donors and during the fractionation of plasma-derived products along with the manufacture and production of the final product. Various regulatory bodies like the WHO; European Commission Directorate-General for Health and Consumers (DG SANCO), EMA, EDQM, and NCAs in the EU; HHS, US FDA, and the CDC, in the US; and Anvisa and COFEPRIS in ROW regulate these processes. Also, the approval process for plasma products is very long. For instance, in China, the plasma products have to go through 10 different stages, which takes a minimum of 22-28 months to receive approval for commercialization in the market by the CFDA. Since the plasma collection and manufacturing units are required to follow these guidelines, which requires high cost and efficiency, many of the new players are unable to enter the market, thus hindering the market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

About Critical Care Therapeutics

Critical care or intensive care is the close monitoring and treatment given to individuals with acute, life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in an ICU or trauma center. Plasma is the fluid portion of the blood, in which all the blood cells are suspended. It makes up about 55% of the total volume of the blood. The other components such as red blood cell (RBC), white blood cell (WBC), and platelets together comprise the remaining 45% of the blood. Plasma is mainly made up of water, which accounts for about 91% of the total volume.

Complete Report Details @
Covered in this report

The report covers the present scenario and the growth prospects of the global critical care therapeutics market for 2017-2021. To calculate the market size, the report considers the revenue generated from sales of critical care therapeutics was considered.

The market is divided into the following segments based on geography:

Global Critical Care Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
CSL Behring
Kedrion Biopharma
Other prominent vendors
Abeona Therapeutics
ADMA Biologics
Asklepios BioPharmaceutical
Aspen Pharma
Bayer HealthCare
Bio Products Laboratory
BioDelivery Sciences
Biogen Idec
Biotest Pharmaceuticals
Bristol-Myers Squibb
Catalyst Biosciences
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals
Mitsubishi Tanabe Pharma
Novo Nordisk
Portola Pharmaceuticals
ProMetic Life Sciences
rEVO Biologics
Rockwell Medical
Shanghai RAAS
Teva Pharmaceutical
The Medicines Company
Thermo Fisher Scientific
Tianjin SinoBiotech & Beijing Bio-Fortune
Ventria Bioscience

Market driver
Growing preference for marketed products over alternative treatment options.
For a full, detailed list, view our report

Market challenge
Existence of plasma fractionation supply and demand gap.
For a full, detailed list, view our report

Market trend
Increased development of recombinant products for critical care use.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Discount On This Report @

For more information, please visit

Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. Market Reports Center’s team consistently works to update and extend our existing repository of market research reports by partnering with new publishers and adding their studies to our website

Sam Collins

303, Astral Court,

Aundh, Pune,

MH - 411045, India

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Critical Care Therapeutics Market Size, Share, Trends, Analysis and Forecasts To 2021 here

News-ID: 428342 • Views: 339

More Releases from MRC

Global 3D Metrology Software Market Size, Status and Forecast 2022
This report studies the global 3D Metrology Software market, analyzes and researches the 3D Metrology Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia. View Report @ This report focuses on the top players in global market, like Carl Zeiss AG Faro Technologies, Inc. H.S. & S. Inc. Heliotis AG Zebicon A/S Creaform Inc. Mitutoyo Corporation Hexagon AB 3d System Corp Nikon Corporation Ge Measurement & Control Solutions Inc. Gom Mbh Perceptron, Inc. Renishaw Plc 3d Digital Corp. Request Sample @
Global Self Guided Torpedo Market Professional Survey Report 2017
This report studies Self Guided Torpedo in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. View Our Report @ This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Atlas Elektronik BAE Systems Lockheed Martin Raytheon Saab Bharat Dynamics Limited (BDL) DCNS Honeywell International Leonardo-Finmeccanica Orbital ATK Download PDF
Global High-Altitude Pseudo Satellites (HAPS) Sales Market Report 2017
In this report, the global High-Altitude Pseudo Satellites (HAPS) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. View Our Report @ Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of High-Altitude Pseudo Satellites (HAPS) for
Global Hyperspectral Remote Sensing Market Future Demand and Growth Analysis 201 …
the following companies as the key players in the global hyperspectral remote sensing market: Corning, Headwall Photonics, ITRES, Norsk Elektro Optikk, and SPECIM Other Prominent Vendors in the market are: BaySpec, Brimrose, CI Systems, Resonon, Telops, and XIMEA. View Our Report @ Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Availability of narrower bandwidths. In hyperspectral remote sensing, narrow bandwidths allow

All 5 Releases

More Releases for Bio

Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the
Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics
Worldwide Bio-Electronics Market 2025 – Global Analysis and Forecasts by Type …
Bio-Electronics is defined as the electronic devices used for bio-medical purposes, and helps in creating and evaluating the new technologies for better understanding of biological systems. The increasing demand of bio-electronics to meet the overwhelming need in healthcare industry will boost the bio-electronics market in forecast period. Furthermore, the growth in research of implantable devices for developing robust and reliable implantable medical devices will increase the demand of bio-electronics in
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description: The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are